Ashvattha Therapeutics Announces Two Oral Presentations at the World Molecular Imaging Congress 2021
Ashvattha will present two oral presentations at the virtual World Molecular Imaging Congress (WMIC), on October 5-8, 2021.
Month: September 2021
Ashvattha Therapeutics Announces Participation at Upcoming Investor Conferences
Ashvattha Chairman, CEO and President Jeffrey Cleland, Ph.D., will be presenting at various virtual and in-person investor conferences in September and October.